Citadel Advisors
HLTH

Citadel Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Citadel Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-449,600
Closed -$73.1K – 15687
2023
Q4 		$73.1K Sell
449,600
-200
-0% -$66 ﹤0.01% 11338
2023
Q3 		$199K Buy
449,800
+13,400
+3% +$6.11K ﹤0.01% 9921
2023
Q2 		$161K Sell
436,400
-2,300
-0.5% -$1.96K ﹤0.01% 10228
2023
Q1 		$798K Sell
438,700
-17,300
-4% -$37.6K ﹤0.01% 7283
2022
Q4 		$944K Buy
456,000
+1,100
+0.2% +$3.48K ﹤0.01% 6930
2022
Q3 		$1.37M Sell
454,900
-124,700
-22% -$442K ﹤0.01% 6335
2022
Q2 		$1.85M Buy
579,600
+372,300
+180% +$2.02M ﹤0.01% 5685
2022
Q1 		$1.34M Sell
207,300
-51,400
-20% -$465K ﹤0.01% 7018
2021
Q4 		$3.47M Buy
+258,700
New +$2.85M ﹤0.01% 5051

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's HLTH Position: Q4 2023 in Review

Citadel Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 4,472 shares — an estimated $1.48K sold.

Citadel Advisors first reported a position in HLTH in Q3 2021 and held it in 3 quarters. The position peaked at $938K in Q3 2021. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Citadel Advisors reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 4,472 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $1.48K.
  • Citadel Advisors first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Citadel Advisors's Cue Health Inc. Common Stock position peaked at $938K in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.